CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Revenue	$ 200,966	$ 164,501	$ 134,902
Costs and expenses:
Cost of revenue	36,175	30,161	25,959
Research and development	57,372	43,873	38,483
Marketing and sales	11,991	11,347	12,301
General and administrative	12,152	9,740	11,408
Total costs and expenses	117,690	95,121	88,151
Income (loss) from operations	83,276	69,380	46,751
Interest and other income, net	2,656	1,283	677
Income before provision for income taxes	85,932	70,663	47,428
Provision for income taxes	25,474	8,303	8,330
Net income	$ 60,458	$ 62,360	$ 39,098
Earnings per share:
Basic (in dollars per share)	$ 23.98	$ 24.61	$ 15.19
Diluted (in dollars per share)	$ 23.49	$ 23.86	$ 14.87
Weighted-average shares used to compute earnings per share:
Basic (in shares)	2,521	2,534	2,574
Diluted (in shares)	2,574	2,614	2,629

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net income	$ 60,458	$ 62,360	$ 39,098
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	18,616	15,498	11,178
Share-based compensation	20,427	16,690	14,027
Deferred income taxes	18,738	(4,738)	131
Unrealized (gain) loss on equity investments	(1,138)	(53)	102
Impairment charges for facilities consolidation	0	383	2,432
Other	(416)	140	309
Changes in assets and liabilities:
Accounts receivable	(1,815)	(1,485)	(2,399)
Prepaid expenses and other current assets	(89)	(698)	559
Other assets	(481)	(270)	(80)
Accounts payable	(14)	373	51
Accrued expenses and other current liabilities	1,077	323	5,081
Other liabilities	437	2,805	624
Net cash provided by operating activities	115,800	91,328	71,113
Cash flows from investing activities
Purchases of property and equipment	(69,691)	(37,256)	(27,045)
Purchases of marketable securities	(36,929)	(25,542)	(2,982)
Sales and maturities of marketable securities	26,874	15,789	6,184
Payments for held-for-sale assets	(2,432)	0	0
Proceeds from Venture distribution	2,554	0	0
Purchases of non-marketable equity investments	(18,330)	(11)	(1)
Acquisitions of businesses and intangible assets	(4,231)	(270)	(629)
Other investing activities	182	140	(22)
Net cash used in investing activities	(102,003)	(47,150)	(24,495)
Cash flows from financing activities
Taxes paid related to net share settlement of equity awards	(18,400)	(13,770)	(7,012)
Repurchases of Class A common stock	(26,248)	(30,125)	(19,774)
Payments for dividends and dividend equivalents	(5,324)	(5,072)	0
Proceeds from issuance of long-term debt, net	29,906	10,432	8,455
Principal payments on finance leases	(2,524)	(1,969)	(1,058)
Other financing activities	2,220	(277)	(111)
Net cash used in financing activities	(20,370)	(40,781)	(19,500)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash equivalents	235	(786)	113
Net increase (decrease) in cash, cash equivalents, and restricted cash equivalents	(6,338)	2,611	27,231
Cash, cash equivalents, and restricted cash equivalents at beginning of the period	45,438	42,827	15,596
Cash, cash equivalents, and restricted cash equivalents at end of the period	39,100	45,438	42,827
Reconciliation of cash, cash equivalents, and restricted cash equivalents to the consolidated balance sheets
Cash and cash equivalents	35,873	43,889	41,862
Restricted cash equivalents, included in prepaid expenses and other current assets	837	353	99
Restricted cash equivalents, included in other assets	2,390	1,196	866
Total cash, cash equivalents, and restricted cash equivalents	39,100	45,438	42,827
Supplemental cash flow data
Cash paid for income taxes, net	7,578	10,554	6,607
Cash paid for interest, net of amounts capitalized	696	486	448
Non-cash investing and financing activities:
Property and equipment in accounts payable and accrued expenses and other current liabilities	9,331	7,127	4,105
Acquisition of businesses and intangible assets in accounts payable, accrued expenses and other current liabilities, and other liabilities	$ 2,659	$ 172	$ 119

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 35,873	$ 43,889
Marketable securities	45,719	33,926
Accounts receivable, net	19,769	16,994
Prepaid expenses and other current assets	7,361	5,236
Total current assets	108,722	100,045
Non-marketable equity investments	27,524	6,070
Property and equipment, net	176,400	121,346
Operating lease right-of-use assets	20,404	14,922
Goodwill	24,534	20,654
Other assets	8,437	13,017
Total assets	366,021	276,054
Current liabilities:
Accounts payable	8,894	7,687
Operating lease liabilities, current	2,213	1,942
Accrued expenses and other current liabilities	30,729	23,967
Total current liabilities	41,836	33,596
Operating lease liabilities, non-current	22,940	18,292
Long-term debt	58,744	28,826
Long-term income taxes	21,005	9,987
Other liabilities	4,253	2,716
Total liabilities	148,778	93,417
Commitments and contingencies
Stockholders' equity:
Common stock, $0.000006 par value; 5,000 million Class A shares authorized, 2,187 million and 2,190 million shares issued and outstanding, as of December 31, 2025 and 2024, respectively; 4,141 million Class B shares authorized, 343 million and 344 million shares issued and outstanding, as of December 31, 2025 and 2024, respectively	0	0
Additional paid-in capital	95,793	83,228
Accumulated other comprehensive income (loss)	271	(3,097)
Retained earnings	121,179	102,506
Total stockholders' equity	217,243	182,637
Total liabilities and stockholders' equity	$ 366,021	$ 276,054